Dan Peer’s Post

Targeting cancer with mRNA-LNPs:key considerations and future prospects. Congrats Edo, Nity, Lior and Inbal - the dream team 😉.

Zahra Davari

Continuous learning📚 | Biomedical Engineering

9mo
Amitabh Wahi

EDUCATIONIST | HIGHER EDUCATION

9mo

Best wishes.

Dr.Satish Rojekar

Drug Delivery Expert | Nanomedicine | Targeted Drug Delivery | Protein and Peptide Drug Delivery | Microneedle| LNPs | Plasma Medicine | Academic Editor-PLOS ONE | Section Editor-Current Pharmaceutical Biotechnology |

9mo

Congratulations 💐💐

Shilpa Gajbhiye

Senior Research Fellow at MET's Institute of Pharmacy Nasik

9mo

Congratulations sir 🎉

Lauren Levy, MD, MBA

Director Business Development

9mo

Congrats. Well done.

Miri Ziv

Past Vice Chairman at ISRAEL CANCER ASSOCIATION-The ICA , Past CEO of the ICA ,for 27 years.

9mo

ברכות על הפירסום החשוב ,הנוסף.

Joseph Steward

Freelance Medical & Scientific Writer | Oncology, Immunotherapy, mRNA Therapeutics, Targeted Therapies | Genomics, Molecular Diagnostics, Biomedical Data Science | Biotech Product Marketing, Publications, Medical Affairs

9mo

Congrats! Looking forward to reading this.

Jai Prakash

Full Professor - Engineered Therapeutics, University of Twente | ERC Advanced Grant Awardee | Managing Director, ScarTec Therapeutics

8mo

Thanks for sharing this amazing review, Daan!

Avi Schroeder

Professor of Chemical Engineering at Technion - Israel Institute of Technology, President-elect CRS

9mo

Congratulations! Fantastic paper!!

Elad Bar Natan

Country Manager at GenScript

9mo

Very interesting!

See more comments

To view or add a comment, sign in

Explore topics